BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29170881)

  • 1. Factors related to longitudinal adherence in colorectal cancer screening: qualitative research findings.
    Benito L; Farre A; Binefa G; Vidal C; Cardona A; Pla M; García M
    Cancer Causes Control; 2018 Jan; 29(1):103-114. PubMed ID: 29170881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons for never and intermittent completion of colorectal cancer screening after receiving multiple rounds of mailed fecal tests.
    Green BB; BlueSpruce J; Tuzzio L; Vernon SW; Aubree Shay L; Catz SL
    BMC Public Health; 2017 May; 17(1):531. PubMed ID: 28558663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000-2008].
    Milà N; García M; Binefa G; Borràs JM; Espinàs JA; Moreno V
    Gac Sanit; 2012; 26(3):217-22. PubMed ID: 22361637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
    Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
    Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
    Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
    Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
    Choi KS; Lee HY; Jun JK; Shin A; Park EC
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening.
    van der Vlugt M; Grobbee EJ; Bossuyt PM; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Essink-Bot ML; Spaander MC; Dekker E
    Br J Cancer; 2017 Jan; 116(1):44-49. PubMed ID: 27923037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea.
    Bae N; Park S; Lim S
    Eur J Oncol Nurs; 2014 Feb; 18(1):72-7. PubMed ID: 24183583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting patient adherence to publicly funded colorectal cancer screening programmes: a systematic review.
    Dressler J; Johnsen AT; Madsen LJ; Rasmussen M; Jorgensen LN
    Public Health; 2021 Jan; 190():67-74. PubMed ID: 33360029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concerns, perceived need and competing priorities: a qualitative exploration of decision-making and non-participation in a population-based flexible sigmoidoscopy screening programme to prevent colorectal cancer.
    Hall N; Birt L; Rees CJ; Walter FM; Elliot S; Ritchie M; Weller D; Rubin G
    BMJ Open; 2016 Nov; 6(11):e012304. PubMed ID: 27836872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study.
    Duncan A; Turnbull D; Wilson C; Osborne JM; Cole SR; Flight I; Young GP
    BMC Public Health; 2014 Mar; 14():238. PubMed ID: 24606951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Colorectal Cancer Screening Participation in Southern Khorasan (Iran).
    Ramazani AA; Norozi E; AmirabadiZadeh H; Ehteshampour AR; Salehiniya H
    J Gastrointest Cancer; 2021 Mar; 52(1):187-191. PubMed ID: 32125621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
    Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
    Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing participation in colorectal cancer screening-a qualitative study in an ethnic and socio-economically diverse inner city population.
    Dharni N; Armstrong D; Chung-Faye G; Wright AJ
    Health Expect; 2017 Aug; 20(4):608-617. PubMed ID: 27550367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the validity of the continuum of resistance model for discriminating early from late and non-uptake of colorectal cancer screening: implications for the design of invitation and reminder letters.
    Gregory T; Cole SR; Wilson CJ; Flight IH; Zajac IT; Turnbull D; Young GP
    Int J Behav Med; 2013 Dec; 20(4):572-81. PubMed ID: 22865004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Educational Intervention Based on Health Belief Model and Social Support on the Rate of Participation of Individuals in Performing Fecal Occult Blood Test for Colorectal Cancer Screening.
    Gholampour Y; Jaderipour A; Khani Jeihooni A; Kashfi SM; Afzali Harsini P
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2777-2787. PubMed ID: 30360606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.
    Garcia M; Borràs JM; Binefa G; Milà N; Espinàs JA; Moreno V
    Eur J Cancer Prev; 2012 Jan; 21(1):42-5. PubMed ID: 21849903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision-making in fecal occult blood test compliance: A quali-quantitative study investigating motivational processes.
    Broc G; Denis B; Fassier JB; Gendre I; Perrin P; Quintard B
    Prev Med; 2017 Dec; 105():58-65. PubMed ID: 28863872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.